Longitudinal Course of GDF15 Levels Before Acute Hospitalization and Death in the General Population

Overview

Journal Geroscience

Specialty Geriatrics

Date 2021 Mar 25

PMID 33763774

Citations 6

Authors

Juliette Tavenier

Ove Andersen

Jan O Nehlin

Janne Petersen

Affiliations

Soon will be listed here.

Abstract

Growth differentiation 15 (GDF15) is a potential novel biomarker of biological aging. To separate the effects of chronological age and birth cohort from biological age, longitudinal studies investigating the associations of GDF15 levels with adverse health outcomes are needed. We investigated changes in GDF15 levels over 10 years in an age-stratified sample of the general population and their relation to the risk of acute hospitalization and death. Serum levels of GDF15 were measured three times in 5-year intervals in 2176 participants aged 30, 40, 50, or 60 years from the Danish population-based DAN-MONICA cohort. We assessed the association of single and repeated GDF15 measurements with the risk of non-traumatic acute hospitalizations. We tested whether changes in GDF15 levels over 10 years differed according to the frequency of hospitalizations within 2 years or survival within 20 years, after the last GDF15 measurement. The change in GDF15 levels over time was dependent on age and sex. Higher GDF15 levels and a greater increase in GDF15 levels were associated with an increased risk of acute hospitalization in adjusted Cox regression analyses. Participants with more frequent admissions within 2 years, and those who died within 20 years, after the last GDF15 measurement already had elevated GDF15 levels at baseline and experienced greater increases in GDF15 levels during the study. The change in GDF15 levels was associated with changes in C-reactive protein and biomarkers of kidney, liver, and cardiac function. Monitoring of GDF15 starting in middle-aged could be valuable for the prediction of adverse health outcomes.

Citing Articles

Blood mitochondrial health markers cf-mtDNA and GDF15 in human aging.

Trumpff C, Huang Q, Michelson J, Liu C, Shire D, Habeck C bioRxiv. 2025; .

PMID: 39974983 PMC: 11838371. DOI: 10.1101/2025.01.28.635306.

Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.

Melero I, de Miguel Luken M, de Velasco G, Garralda E, Martin-Liberal J, Joerger M Nature. 2024; 637(8048):1218-1227.

PMID: 39663448 PMC: 11779642. DOI: 10.1038/s41586-024-08305-z.

Is There a Role for Growth and Differentiation Factor-15 in B-Cell Lymphoproliferative Neoplasms?.

Agic D, Cabarkapa V, Milosevic I, Percic I, El Farra A, Nikolic S Indian J Hematol Blood Transfus. 2024; 40(2):213-219.

PMID: 38708149 PMC: 11065822. DOI: 10.1007/s12288-023-01695-6.

Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans.

Pena-Leon V, Perez-Lois R, Villalon M, Folgueira C, Barja-Fernandez S, Prida E J Endocrinol Invest. 2023; 47(5):1139-1154.

PMID: 37955834 DOI: 10.1007/s40618-023-02232-y.

Association between aging-related biomarkers and longitudinal trajectories of intrinsic capacity in older adults.

Lu W, Guyonnet S, Martinez L, Lucas A, Parini A, Vellas B Geroscience. 2023; 45(6):3409-3418.

PMID: 37620614 PMC: 10643641. DOI: 10.1007/s11357-023-00906-2.

References

Lehallier B, Gate D, Schaum N, Nanasi T, Lee S, Yousef H . Undulating changes in human plasma proteome profiles across the lifespan. Nat Med. 2019; 25(12):1843-1850. PMC: 7062043. DOI: 10.1038/s41591-019-0673-2. View

Brown C, Roth D, Allman R, Sawyer P, Ritchie C, Roseman J . Trajectories of life-space mobility after hospitalization. Ann Intern Med. 2009; 150(6):372-8. PMC: 2802817. DOI: 10.7326/0003-4819-150-6-200903170-00005. View

Wollert K, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Allhoff T . Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Circulation. 2007; 116(14):1540-8. DOI: 10.1161/CIRCULATIONAHA.107.697714. View

Kempf T, Bjorklund E, Olofsson S, Lindahl B, Allhoff T, Peter T . Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur Heart J. 2007; 28(23):2858-65. DOI: 10.1093/eurheartj/ehm465. View

Rothenbacher D, Dallmeier D, Christow H, Koenig W, Denkinger M, Klenk J . Association of growth differentiation factor 15 with other key biomarkers, functional parameters and mortality in community-dwelling older adults. Age Ageing. 2019; 48(4):541-546. DOI: 10.1093/ageing/afz022. View

Fried L, Tangen C, Walston J, Newman A, Hirsch C, Gottdiener J . Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3):M146-56. DOI: 10.1093/gerona/56.3.m146. View

Gordon S, Baker N, Kidd M, Maeder A, Grimmer K . Pre-frailty factors in community-dwelling 40-75 year olds: opportunities for successful ageing. BMC Geriatr. 2020; 20(1):96. PMC: 7060633. DOI: 10.1186/s12877-020-1490-7. View

Byles J, DEste C, Parkinson L, OConnell R, Treloar C . Single index of multimorbidity did not predict multiple outcomes. J Clin Epidemiol. 2005; 58(10):997-1005. DOI: 10.1016/j.jclinepi.2005.02.025. View

Moore A, Brown D, Fairlie W, Bauskin A, Brown P, Munier M . The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab. 2001; 85(12):4781-8. DOI: 10.1210/jcem.85.12.7007. View

10.

Emmerson P, Duffin K, Chintharlapalli S, Wu X . GDF15 and Growth Control. Front Physiol. 2018; 9:1712. PMC: 6277789. DOI: 10.3389/fphys.2018.01712. View

11.

Tavenier J, Hartmann Rasmussen L, Andersen A, Houlind M, Langkilde A, Andersen O . Association of GDF15 With Inflammation and Physical Function During Aging and Recovery After Acute Hospitalization: A Longitudinal Study of Older Patients and Age-Matched Controls. J Gerontol A Biol Sci Med Sci. 2021; 76(6):964-974. DOI: 10.1093/gerona/glab011. View

12.

Skaaby T, Nystrup Husemoen L, Borglykke A, Jorgensen T, Thuesen B, Pisinger C . Vitamin D status, liver enzymes, and incident liver disease and mortality: a general population study. Endocrine. 2013; 47(1):213-20. DOI: 10.1007/s12020-013-0107-8. View

13.

Tsai V, Husaini Y, Sainsbury A, Brown D, Breit S . The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases. Cell Metab. 2018; 28(3):353-368. DOI: 10.1016/j.cmet.2018.07.018. View

14.

Adriaensen W, Mathei C, Vaes B, Van Pottelbergh G, Wallemacq P, Degryse J . Interleukin-6 as a first-rated serum inflammatory marker to predict mortality and hospitalization in the oldest old: A regression and CART approach in the BELFRAIL study. Exp Gerontol. 2015; 69:53-61. DOI: 10.1016/j.exger.2015.06.005. View

15.

Juul-Larsen H, Christensen L, Bandholm T, Andersen O, Kallemose T, Jorgensen L . Patterns of Multimorbidity and Differences in Healthcare Utilization and Complexity Among Acutely Hospitalized Medical Patients (≥65 Years) - A Latent Class Approach. Clin Epidemiol. 2020; 12:245-259. PMC: 7053819. DOI: 10.2147/CLEP.S226586. View

16.

Ranasinghe I, Wang Y, Dharmarajan K, Hsieh A, Bernheim S, Krumholz H . Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohort study. PLoS Med. 2014; 11(9):e1001737. PMC: 4181962. DOI: 10.1371/journal.pmed.1001737. View

17.

Eggers K, Kempf T, Wallentin L, Wollert K, Lind L . Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals. Clin Chem. 2013; 59(7):1091-8. DOI: 10.1373/clinchem.2012.201210. View

18.

Nieminen M, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola V . EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006; 27(22):2725-36. DOI: 10.1093/eurheartj/ehl193. View

19.

Breit S, Carrero J, Tsai V, Yagoutifam N, Luo W, Kuffner T . Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant. 2011; 27(1):70-5. DOI: 10.1093/ndt/gfr575. View

20.

Ambye L, Rasmussen S, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S . Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res Clin Pract. 2005; 67(2):175-9. DOI: 10.1016/j.diabres.2004.06.013. View